Skip to main content
PMC home page
Japanese Journal of Cancer Research : Gann logoLink to Japanese Journal of Cancer Research : Gann
. 1997 Nov;88(11):1078–1086. doi: 10.1111/j.1349-7006.1997.tb00332.x

A High Prevalence of Functional Inactivation by Methylation Modification of p16INK4A/CDKN2/MTS1 Gene in Primary Urothelial Cancers

Toshiya Akao 1,2, Yoshiyuki Kakehi 1, Noriyuki Itoh 1, Enver Özdemir 1, Takashi Shimizu 2, Akira Tachibana 2, Masao S Sasaki 2, Osamu Yoshida 1,✉
PMCID: PMC5921315  PMID: 9439683

Abstract

We analyzed the genetic and epigenetic alterations p16INK4A/CDKN2/MTSl gene (MTS1 gene) in 38 primary urothelial cancers. Genetic alterations of the MTS1 gene consisted of one base substitution mutation in exon 2(2.6%)and 6 homozygous deletions (16.2%). Hypermethylation of the 5’CpG island in exon 1 of theMTS1 genewas observed in 12 tumors (37.5%). Consequently, 19 of 38 tumors (50%) showed genetic alterations or epigenetic hypermethylation of the MTS1 gene. Retention of hypermethylated MTS1 gene(s) in 36% of the tumors showing loss of heterozygosity at the critical region indicates that the methylation modification could be an initial event followed by genomic rearrangements associated with total loss of MTS1 gene function. Immunohistochemical analysis of MTS1 expression revealed that all the tumors with genetic alterations of the MTS1 gene and 9 of 12 highly methylated tumors displayed an absence of MTS1 nuclear antigen. Genetic and epigenetic changes of theMTS1 gene were not correlated with the grade and stage of tumors, indicating that these alterations are early events in nrothelial carcinogenesis, in which functional inactivation by hypermethylation is a predominant mechanism.

Keywords: Hypermethylation, MTS1, Urothelial cancer

Full Text

The Full Text of this article is available as a PDF (611.1 KB).

REFERENCES

  • 1. ) Reznikoff , C. A. , Belair , C. D. , Yeager , T. R. , Savelieva , E. , Blelloch , R. H. , Puthenveettil , J. A. and Cuthill , S. Amolecular genetic model of human bladder cancer patho‐genesis . Semin. Oncol , 23 , 571 – 584 ( 1996. ). [PubMed] [Google Scholar]
  • 2. ) Ishikawa , J. , Xu , H. J. , Hu , S. X. , Yandell , D. W. , Maeda , S‐ , Kamidono , S. , Benedict , W. F. and Takahashi , R , Inactivation of the retinoblastoma gene in human bladder and renal cell carcinomas . Cancer Res. , 52 , 5736 – 5743 ( 1991. ). [PubMed] [Google Scholar]
  • 3. ) Xu , H. J. , Cairns , P. , Hu , S. X. , Knowles , M. A. and Benedict , W. F.Loss of RB protein expression in primary bladder cancer correlates with loss of heterozygosity at the RB locus and tumor progression . Int. J. Cancer , 53 , 781 – 784 ( 1993. ). [DOI] [PubMed] [Google Scholar]
  • 4. ) Miyamoto , H. , Kubota , Y. , Torigoe , S. , Iwasaki , Y. and Shuin , T.Retinoblastoma gene mutations in primary human bladder cancer . Br. J. Cancer , 71 , 831 – 835 ( 1995. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5. ) Schlechte , H. H. , Schnorr , D. , Loning , T. , Rudolph , B. D. , Pohrt , U. M. and Loening , S. A.Mutation of the tumor suppressor gene p53 in human prostate and bladder can‐ cers‐investigation by temperature gradient gel electro‐phoresis (TGGE) . J. Urol , 157 , 1049 – 1053 ( 1997. ). [PubMed] [Google Scholar]
  • 6. ) Özdemir , E. , Kakehi , Y. , Okuno , H. , Habuchi , T. , Okada , Y. and Yoshida , O.Strong correlation of basement membrane degradation with p53 inactivation and/or mdm2 overexpression in superficial urothelial carcinomas . J. Urol. , 158 , 206 – 211 ( 1997. ). [DOI] [PubMed] [Google Scholar]
  • 7. ) Cairns , P. , Shaw , M. E. and Knowles , M. A.Initiation of bladder cancer may involve deletion of a tumor‐suppressor gene on chromosome 9 . Oncogens , 8 , 1083 – 1085 ( 1993. ). [PubMed] [Google Scholar]
  • 8. ) Miyao , N. , Tsai , Y. C. , Lerner , S. P. , Olumi , A. F. , Spruck , C. H. , III , Gonzalez‐Zulueta , M. , Nichols , P. W. , Skinner , D. G. and Jones , P. A.Role of chromosome 9 in human bladder cancer . Cancer Res. , 53 , 4066 – 4070 ( 1993. ). [PubMed] [Google Scholar]
  • 9. ) Orlow , I. , Lianes , P. , Lacombe , L. , Dalbagni , G. , Renter , V. E. and Cordon‐Cardo , C.Chromosome 9 allelic losses and microsatellite alterations in human bladder tumors . Cancer Res. , 54 , 2848 – 2851 ( 1994. ). [PubMed] [Google Scholar]
  • 10. ) Kamb , A. , Gruis , N. A. , Weaver‐Feldhaus , J. , Liu , Q. , Harshman , K. , Tavtigian , S. V. , Stockert , E. , Day , R. S. , III , Johnson , B. E. and Skolnick , M. H.A cell cycle regulator potentially involved in genesis of many tumor types . Science , 264 , 436 – 440 ( 1994. ). [DOI] [PubMed] [Google Scholar]
  • 11. ) Nobori , T. , Miura , K. , Wu , D. J. , Lois , A. , Takabayashi , K. and Carson , D. A.Deletions of the cyclin‐dependent kinase‐4 inhibitor gene in multiple human cancers . Nature , 368 , 753 – 756 ( 1994. ). [DOI] [PubMed] [Google Scholar]
  • 12. ) Serrano , M. , Hannon , G. J. and Beach , D. A.New regulatory motif in cell‐cycle control causing specific inhibition of cyclin D/CDK4 . Nature , 366 , 704 – 707 ( 1993. ). [DOI] [PubMed] [Google Scholar]
  • 13. ) Hannon , G. J. and Beach , D.p15INK4B is a potential effector of TGF‐β‐induced cell cycle arrest . Nature , 371 , 257 – 261 ( 1994. ). [DOI] [PubMed] [Google Scholar]
  • 14. ) Cairns , P. , Mao , L. , Merlo , A. , Lee , D. J. , Schwab , D. , Eby , Y. , Tokino , K. , Van Der Riet , P. , Blaugrund , J. E. and Sidransky , D.Rates of p16 (MTS1) mutations in primary tumors with 9p loss . Science , 265 , 415 – 416 ( 1994. ). [DOI] [PubMed] [Google Scholar]
  • 15. ) Spruck , C. H. , III , Gonzalez‐Zulueta , M. , Shibata , A. , Simoneau , A. , Lin , M.‐F. , Gonzales , F. , Tsai , Y. C. and Jones , P. A.p16 gene in uncultured tumors . Nature , 370 , 183 – 184 ( 1994. ). [DOI] [PubMed] [Google Scholar]
  • 16. ) Merlo , A. , Herman , J. G. , Mao , L. , Lee , D. J. , Gabrielson , E. , Burger , P. C. , Baylin , S. B. and Sidransky , D.5′ CpG island methylation is associated with transcriptional silencing of the tumor suppressor p16/CDKN2/MTSl in human cancers . Nat Med. , 1 , 686 – 692 ( 1995. ). [DOI] [PubMed] [Google Scholar]
  • 17. ) Herman , J. G. , Merlo , A. , Mao , L. , Lapidus , R. G. , Issa , J.‐P. J. , Davidson , N. E. , Sidransky , D. and Baylin , S. B.Inactivation of the CDKN2/pl6/MTSl gene is frequently associated with aberrant DNA methylation in all common human cancers . Cancer Res. , 55 , 4525 – 4530 ( 1995. ). [PubMed] [Google Scholar]
  • 18. ) Read , A. L. , Califano , J. , Cairns , P. , Westra , W. H. , Jones , R. M. , Koch , W. , Ahrendt , S. , Eby , Y. , Sewell , D. , Nawroz , H. , Bartek , J. and Sidransky , D.High frequency of p16 (CDKN2/MTS1/INK4A) inactivation in head and neck squamous cell carcinoma . Cancer Res. , 56 , 3630 – 3633 ( 1996. ). [PubMed] [Google Scholar]
  • 19. ) Gonzalez‐Zulueta , M. , Bender , C. M. , Yang , A. S. , Nguyen , T. , Beart , R. W. , Van Tornout , J. M. and Jones , P. A.Methylation of the 5′ CpG island of the p16/ CDKN2 tumor suppressor gene in normal and transformed human tissue correlates with gene silencing . Cancer Res. , 55 , 4531 – 4535 ( 1995. ). [PubMed] [Google Scholar]
  • 20. ) Cairns , P. , Polascik , T. J. , Eby , Y. , Tokino , K. , Califano , J. , Merlo , A. , Mao , L. , Herath , J. , Jenkins , R. , Westra , W. , Rutter , J. L. , Buckler , A. , Gabrielson , E. , Tockman , M. , Cho , K. R. , Hedrick , L. , Bova , G. S. , Issacs , W. , Koch , W. , Schwab , D. and Sidransky , D.Frequency of homo‐zygous deletion at p16/CDKN2 in primary human tumors . Nat Genet. , 210 – 212 ( 1995. ). [DOI] [PubMed]
  • 21. ) Mostofi , F. K. , Sobin , L. H. and Torloni , H.“Histological Typing of Urinary Bladder Tumors” ( 1973. ). World Health Organization; , Geneva . [Google Scholar]
  • 22. ) UICC. “ TNM Classification of Malignant Tumors ,” 4th Ed. , ed. Hermanek P. and Sobin L. H. ( 1987. ). Springer; , Geneva . [Google Scholar]
  • 23. ) Shimizu , T. , Toguchida , J. , Kato , M. V. , Kaneko , A. , Ishizaki , K. and Sasaki , M. S.Detection of mutations of the RBI gene in retinoblastoma patients by using exon‐by‐exon PCR‐SSCP analysis . Am. J. Hum. Genet , 54 , 793 – 800 ( 1994. ). [PMC free article] [PubMed] [Google Scholar]
  • 24. ) Cannon‐Albright , L. A. , Goldgar , D. E. , Meyer , L. J. , Lewis , C. M. , Anderson , D. E. , Fountain , J. W. , Hegi , M. E. , Wiseman , R. W. , Petty , E. M. , Bale , A. E. , Olopade , O. L , Diaz , M. O. , Kwiatkowski , D. J. , Piepkorn , M. W. , Zone , J. J. and Skolnick , M. H.Assignment of a locus for familial melanoma, MLM, to chromosome 9pl3‐p22 . Science , 258 , 1148 – 1152 ( 1992. ). [DOI] [PubMed] [Google Scholar]
  • 25. ) Cheng , J. Q. , Jhanwar , S. C. , Lu , Y. Y. and Testa , J. R.Homozygous deletions within 9p21‐p22 identify a small critical region of chromosomal loss in human malignant mesotheliomas . Cancer Res. , 53 , 4761 – 4763 ( 1993. ). [PubMed] [Google Scholar]
  • 26. ) Packenham , J. P. , Taylor , J. A. , Anna , C. H. , White , C. M. and Devereux , T. R.Homozygous deletions but no sequence mutations in coding regions of p15 or p16 in human primary bladder tumors . Mol. Carcinog. , 14 , 147 – 151 ( 1995. ). [DOI] [PubMed] [Google Scholar]
  • 27. ) Williamson , M. P. , Elder , P. A. , Shaw , M. E. , Devlin , J. and Knowles , M. A.p16 (CDKN2) is a major deletion target at 9p21 in bladder cancer . Hum, Mol. Genet. , 4 , 1569 – 1577 ( 1995. ). [DOI] [PubMed] [Google Scholar]
  • 28. ) Caldas , C. , Hahan , S. A. , Da Costa , L. T. , Redston , M. S. , Schiitte , M. , Seymour , A. B. , Weinstein , C. L. , Hurban , R. H. , Yeo , C. J. and Kern , S. E.Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinoma . Nat. Genet , 8 , 27 – 32 ( 1994. ). [DOI] [PubMed] [Google Scholar]
  • 29. ) Mori , T. , Miura , K. , Aoki , T. , Nishihira , T. , Mori , S. and Nakamura , Y.Frequent somatic mutations of the MTS1/ CDK4I (multiple tumor suppressor/cyclin‐dependent kinase 4 inhibitor) gene in esophageal squamous cell carcinoma . Cancer Res. , 54 , 3396 – 3397 ( 1994. ). [PubMed] [Google Scholar]
  • 30. ) Okamoto , A. , Hussain , S. P. , Hagiwara , K. , Spillare , E. A. , Rusin , M. R. , Demetrick , D. J. , Serrano , M. , Hannon , G. J. , Shiseki , M. , Zariwala , M. , Xiong , Y. , Beach , D. H. , Yokota , J. and Harris , C. C.Mutations in the pl6INK4/MTSl/CDKN2, pl5INK4D/MTS2, and p18 genes in primary and metastatic lung cancer . Cancer Res. , 55 , 1448 – 1451 ( 1995. ). [PubMed] [Google Scholar]
  • 31. ) Kinoshita , H. , Yamada , H. , Ogawa , O. , Kakehi , Y. , Osaka , M. , Nakamura , E. , Mishina , M. , Habuchi , T. , Takahashi , R. , Sugiyama , T. and Yoshida , O.Contribution of chromosome 9p21–22 deletion to the progression of human renal cell carcinoma . Jpn. J. Cancer Res. , 86 , 795 – 799 ( 1995. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32. ) Orlow , I. , Lacombe , L. , Hannon , G. J. , Serrano , M. , Pellicer , I. , Dalbagni , G. , Reuter , V. E. , Zhang , Z.‐F. , Beach , D. and Coedon‐Cardo , C.Deletion of the p16 and p15 genes in human bladder tumors , J. Natl. Cancer Inst , 87 , 1524 – 1529 ( 1995. ). [DOI] [PubMed] [Google Scholar]
  • 33. ) Hsieh , C.‐L.Dependence of transcriptional repression on CpG methylation density . Mol Cell. Biol , 14 , 5487 – 5494 ( 1994. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34. ) Boyes , J. and Bird , A.Repression of genes by DNA methylation depends on CpG density and promoter strength: evidence for involvement of a methyl‐CpG binding protein . EMSO J. , 11 , 327 – 333 ( 1992. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35. ) Geradts , J. and Wilson , P. A.High frequency of aberrant pl6INKlA expression in human breast cancer . Am. J. Hum. Pathol , 149 , 15 – 20 ( 1996. ). [PMC free article] [PubMed] [Google Scholar]
  • 36. ) Greenblatt , M. S. , Bennett , W. P. , Hollstein , M. and Harris , C. C.Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis . Cancer Res. , 54 , 4855 – 4877 ( 1994. ). [PubMed] [Google Scholar]
  • 37. ) Jones , P. A. , Rideout , W. M. , III , Shen , J. C. , Spruck , C. H. and Tsai , Y. C.Methylation, mutation and cancer . Bioessays , 14 , 33 – 36 ( 1992. ). [DOI] [PubMed] [Google Scholar]
  • 38. ) Schmiitte , C. , Yang , A. S. , Nguyen , T. T. , Heart , R. W. and Jones , P. A.Mechanism for the involvement of DNA methylation in colon carcinogenesis . Cancer Res. , 56 , 2375 – 2381 ( 1996. ). [PubMed] [Google Scholar]
  • 39. ) Shen , J. C. , Rideout , W. M. , III and Jones , P. A.High frequency mutagenesis by a DNA methyltransferase . Cell , 71 , 1073 – 1080 ( 1992. ). [DOI] [PubMed] [Google Scholar]

Articles from Japanese Journal of Cancer Research : Gann are provided here courtesy of Wiley

RESOURCES